| Tissue |
Pathology |
Catalog No. |
| |
|
Tumor |
Adjacent Tissue |
| Abdomen |
Adenocarcinoma with mucinous features |
O20-0025 |
O21-0025 |
| |
Adrenal cortical adenoma |
O20-0050 |
O21-0050 |
| |
Adrenal myelolipoma |
O20-0075 |
O21-0075 |
| |
Malignant fibrous histocytoma |
O20-0100 |
O21-0100 |
| |
Mature ganglioneuroma |
O20-0125 |
O21-0125 |
| |
Pheochromocytoma |
O20-0150 |
O21-0150 |
| |
Poorly differentiated carcinoma |
O20-0175 |
O21-0175 |
| |
Renal cell carcinoma |
O20-0200 |
O21-0200 |
| |
Squamous cell carcinoma |
O20-0225 |
O21-0225 |
| |
|
|
|
| Bladder |
Adenocarcinoma |
O20-0250 |
O21-0250 |
| |
Squamous cell carcinoma |
O20-0275 |
O21-0275 |
| |
Urothelial carcinoma |
O20-0300 |
O21-0300 |
| |
Urothelial hyperplasia |
O20-0325 |
O21-0325 |
| Bone |
Osteochondroma |
O20-0350 |
O21-0350 |
| |
Osteosarcoma |
O20-0375 |
O21-0375 |
| Brain |
Glioblastoma |
O20-0400 |
O21-0400 |
| Breast |
Adenocarcinoma |
O20-0425 |
O21-0425 |
| |
Carcinoma |
O20-0450 |
O21-0450 |
| |
Ductal Carcinoma, all grades |
O20-0475 |
O21-0475 |
| |
Fibroadenoma |
O20-0500 |
O21-0500 |
| |
Fibroadenomatous changes |
O20-0525 |
O21-0525 |
| |
Lobular carcinoma, all grades |
O20-0550 |
O21-0550 |
| |
Malignant phylloides tumor |
O20-0575 |
O21-0575 |
| |
Medullary carcinoma |
O20-0600 |
O21-0600 |
| |
Mixed lobular and ductal carcinoma |
O20-0625 |
O21-0625 |
| |
Mucinous carcinoma |
O20-0650 |
O21-0650 |
| |
Papillary carcinoma |
O20-0675 |
O21-0675 |
| |
Squamous cell carcinoma |
O20-0700 |
O21-0700 |
| |
Tubular carcinoma |
O20-0725 |
O21-0725 |
| |
|
|
|
| Cecum |
Adenocarcinoma |
O20-0750 |
O21-0750 |
| Cervix |
Chronic cervicitis |
O20-0775 |
O21-0775 |
| |
Chronic cystic cervicitis |
O20-0800 |
O21-0800 |
| |
Cystadenocarcinoma |
O20-0825 |
O21-0825 |
| |
Cystic endocervical tunnel clusters |
O20-0850 |
O21-0850 |
| |
Nabothian cysts |
O20-0875 |
O21-0875 |
| |
Squamous cell carcinoma of cervix |
O20-0900 |
O21-0900 |
| |
Squamous metaplasia |
O20-0925 |
O21-0925 |
| Colon |
Adenocarcinoma |
O20-0950 |
O21-0950 |
| |
Metastatic lymphoma |
O20-0975 |
O21-0975 |
| |
Mucinous adenocarcinoma |
O20-1000 |
O21-1000 |
| |
Spindle cell tumor, consistent with cystosarcoma Phyllodes |
O20-1025 |
O21-1025 |
| |
Tubulovillous carcinoma |
O20-1050 |
O21-1050 |
| Corpus Luteum |
Hemorrhagic corpus luteum cysts |
O20-1075 |
O21-1075 |
| |
|
|
|
| Diaphragm |
Adenocarcinoma |
O20-1100 |
O21-1100 |
| Duodenum |
Adenocarcinoma |
O20-1125 |
O21-1125 |
| |
|
|
|
| Ear |
Basal cell carcinoma |
O20-1150 |
O21-1150 |
| |
Squamous cell carcinoma |
O20-1175 |
O21-1175 |
| Endometrium |
Adenocarcinoma of endometrium |
O20-1200 |
O21-1200 |
| |
Carcinosarcoma of endometrium |
O20-1225 |
O21-1225 |
| |
Leiomyomata uteri |
O20-1250 |
O21-1250 |
| |
Leiomyosarcoma |
O20-1275 |
O21-1275 |
| Esophagus |
Adenocarcinoma |
O20-1300 |
O21-1300 |
| |
Small cell carcinoma |
O20-1325 |
O21-1325 |
| |
Squamous cell carcinoma |
O20-1350 |
O21-1350 |
| |
|
|
|
| Fallopian Tube |
Hydatid cysts |
O20-1375 |
O21-1375 |
| |
Paratubal cyst |
O20-1400 |
O21-1400 |
| |
Serosal endometriosis, follicle cysts |
O20-1425 |
O21-1425 |
| |
Serous cystadenoma |
O20-1450 |
O21-1450 |
| |
|
|
|
| Gallbladder |
Adenocarcinoma |
O20-1500 |
O21-1500 |
| |
Chronic cholecystitis, Cholesterolosis |
O20-1525 |
O21-1525 |
| |
Leiomyoma |
O20-1550 |
O21-1550 |
| |
|
|
|
| Illeum |
Adenocarcinoma |
O20-1575 |
O21-1575 |
| |
|
|
|
| Jejunum |
Adenocarcinoma |
O20-1600 |
O21-1600 |
| |
|
|
|
| Kidney |
Adenocarcinoma |
O20-1625 |
O21-1625 |
| |
Angiomyolipoma |
O20-1650 |
O21-1650 |
| |
Carcinosarcoma |
O20-1675 |
O21-1675 |
| |
Ductal carcinoma |
O20-1700 |
O21-1700 |
| |
Neuroendocrine carcinoma |
O20-1725 |
O21-1725 |
| |
Papillary renal cell carcinoma |
O20-1750 |
O21-1750 |
| |
Polycystic kidney disease |
O20-1775 |
O21-1775 |
| |
Pyelonephritis |
O20-1800 |
O21-1800 |
| |
Renal cell carcinoma, clear-cell |
O20-1825 |
O21-1825 |
| |
Renal oncocytoma |
O20-1850 |
O21-1850 |
| |
Solitary multilocular cyst of kidney |
O20-1875 |
O21-1875 |
| |
Urothelial carcinoma |
O20-1900 |
O21-1900 |
| |
|
|
|
| Larynx |
Adenomyosis and Leiomyoma |
O20-1925 |
O21-1925 |
| |
Squamous cell carcinoma |
O20-1950 |
O21-1950 |
| Lipoma |
Squamous cell carcinoma |
O20-1975 |
O21-1975 |
| Liver |
Adenocarcinoma |
O20-2000 |
O21-2000 |
| |
Hepatocellular carcinoma |
O20-2025 |
O21-2025 |
| |
Metastatic squamous call carcinoma |
O20-2050 |
O21-2050 |
| |
Leiomyosarcoma |
O20-2075 |
O21-2075 |
| Lung |
Adenocarcinoma |
O20-2100 |
O21-2100 |
| |
Bronchioalveolar carcinoma |
O20-2125 |
O21-2125 |
| |
Carcinoma |
O20-2150 |
O21-2150 |
| |
Hamartoma (adenochondroma) |
O20-2175 |
O21-2175 |
| |
Hyalinized nodule, suggestive of remote granuloma |
O20-2200 |
O21-2200 |
| |
Large cell carcinoma |
O20-2225 |
O21-2225 |
| |
Non-caseating granulomatous inflammation |
O20-2250 |
O21-2250 |
| |
Non-small cell carcinoma |
O20-2275 |
O21-2275 |
| |
Small cell carcinoma |
O20-2300 |
O21-2300 |
| Lymph Node |
Adenocarcinoma |
O20-2325 |
O21-2325 |
| |
Carcinoma, small cell type |
O20-2350 |
O21-2350 |
| |
Ductal carcinoma |
O20-2375 |
O21-2375 |
| |
Follicular lymphoma |
O20-2400 |
O21-2400 |
| |
Metastatic desmoplastic melanoma |
O20-2425 |
O21-2425 |
| |
Metastatic papillary carcinoma |
O20-2450 |
O21-2450 |
| |
Squamous cell carcinoma |
O20-2475 |
O21-2475 |
| |
Urothelial carcinoma |
O20-2500 |
O21-2500 |
| |
Warthin's Tumor |
O20-2525 |
O21-2525 |
| |
|
|
|
| Mandible |
Squamous cell carcinoma |
O20-2550 |
O21-2550 |
| Mediastinum |
Adenocarcinoma |
O20-2575 |
O21-2575 |
| Mouth |
Squamous cell carcinoma |
|
|
| Muscle |
Malignant mesothelioma |
O20-2600 |
O21-2600 |
| |
Squamous cell carcinoma |
O20-2625 |
O21-2625 |
| Myometrium |
Adenomyosis |
O20-2650 |
O21-2650 |
| |
Cystic uterus |
O20-2675 |
O21-2675 |
| |
Endometrial adenocarcinoma |
O20-2700 |
O21-2700 |
| |
Endometrioid carcinoma |
O20-2725 |
O21-2725 |
| |
Large cell carcinoma |
O20-2750 |
O21-2750 |
| |
Leiomyomas |
O20-2775 |
O21-2775 |
| |
Leiomyosarcoma |
O20-2800 |
O21-2800 |
| |
|
|
|
| Neuroblastoma |
Olfactory neuroblastoma (esthesioneuroblastoma) |
O20-2825 |
O21-2825 |
| |
|
|
|
| Omentum |
Adenocarcinoma |
O20-2850 |
O21-2850 |
| |
Metastatic carcinoma |
O20-2875 |
O21-2875 |
| |
Papillary serous carcinoma |
O20-2900 |
O21-2900 |
| |
Portion of colon with an extensive tumor of the mesentery |
O20-2925 |
O21-2925 |
| |
Squamous cell carcinoma |
O20-2950 |
O21-2950 |
| Ovary |
Adenocarcinoma |
O20-2975 |
O21-2975 |
| |
Carcinoma of soft tissue |
O20-3000 |
O21-3000 |
| |
Fibroma |
O20-3025 |
O21-3025 |
| |
Follicular and surface inclusion cysts |
O20-3050 |
O21-3050 |
| |
Hemorrhagic corpus luteum cysts |
O20-3075 |
O21-3075 |
| |
Hemorrhagic cysts |
O20-3100 |
O21-3100 |
| |
Luteal cysts and benign follicular cysts |
O20-3125 |
O21-3125 |
| |
Malignant lymphoma |
O20-3150 |
O21-3150 |
| |
Mature Cystic Teratoma |
O20-3175 |
O21-3175 |
| |
Mucinous cystadenoma |
O20-3200 |
O21-3200 |
| |
Mullerian cysts |
O20-3225 |
O21-3225 |
| |
Serous cystadenoma |
O20-3250 |
O21-3250 |
| |
Squamous cell carcinoma |
O20-3275 |
O21-3275 |
| |
|
|
|
| Pancreas |
Acinar cell carcinoma |
O20-3300 |
O21-3300 |
| |
Adenocarcinoma |
O20-3325 |
O21-3325 |
| |
Distal pancreatic mass |
O20-3350 |
O21-3350 |
| |
Pancreatic islet cell tumor |
O20-3375 |
O21-3375 |
| |
Pancreatic pseudocyst |
O20-3400 |
O21-3400 |
| |
Sarcoma |
O20-3425 |
O21-3425 |
| |
Paraganglioma |
|
|
| |
Parapharyngeal |
O20-3450 |
O21-3450 |
| Parathyroid |
Parathyroid adenoma |
O20-3475 |
O21-3475 |
| Paratracheal Mass |
Metastatic medullary carcinoma |
O20-3500 |
O21-3500 |
| |
Paratubal Cyst |
O20-3525 |
O21-3525 |
| Parotid |
Adenocarcinoma |
O20-3550 |
O21-3550 |
| |
Adenoid cystic carcinoma |
O20-3575 |
O21-3575 |
| |
B-lymphoblastic lymphoma |
O20-3600 |
O21-3600 |
| |
Monomorphic adenoma |
O20-3625 |
O21-3625 |
| |
Oncocytoma |
O20-3650 |
O21-3650 |
| |
Pleomorphic adenoma |
O20-3675 |
O21-3675 |
| |
Schwannoma |
O20-3700 |
O21-3700 |
| |
Squamous cell carcinoma with keratinization |
O20-3725 |
O21-3725 |
| |
Warthin's tumor |
O20-3750 |
O21-3750 |
| Pelvic mass |
Invasive adenocarcinoma |
O20-3775 |
O21-3775 |
| |
Malignant gastrointestinal stromal tumor |
O20-3800 |
O21-3800 |
| |
Myxoid neurofibroma |
O20-3825 |
O21-3825 |
| |
Pelvic fibromatosis (Desmoid turmor) |
O20-3850 |
O21-3850 |
| |
Pleomorphic adenoma |
O20-3875 |
O21-3875 |
| |
Warthin tumor |
O20-3900 |
O21-3900 |
| Penis |
Leiomyomas |
O20-3925 |
O21-3925 |
| Peritoneum |
Adenocarcinoma |
O20-3950 |
O21-3950 |
| |
Metastatic papillary serous carcinoma |
O20-3975 |
O21-3975 |
| Placenta |
Metastatic anaplastic carcinoma |
O20-4000 |
O21-4000 |
| |
Metastatic squamous cell carcinoma |
O20-4025 |
O21-4025 |
| |
Squamous cell carcinoma |
O20-4050 |
O21-4050 |
| Pleura |
Carcinoma |
O20-4075 |
O21-4075 |
| |
Malignant mesothelioma |
O20-4100 |
O21-4100 |
| Prostate |
Adenocarcinoma |
O20-4125 |
O21-4125 |
| |
Adenocarcinoma, acinar type |
O20-4150 |
O21-4150 |
| |
Carcinoma |
O20-4175 |
O21-4175 |
| |
Glandular hyperplasia |
O20-4200 |
O21-4200 |
| |
|
|
|
| Rectum |
Adenocarcinoma |
O20-4225 |
O21-4225 |
| |
|
|
|
| Scrotum |
Adenocarcinoma |
O20-4250 |
O21-4250 |
| Seminal Vesicle |
Adenocarcinoma |
O20-4275 |
O21-4275 |
| |
Squamous cell carcinoma |
O20-4300 |
O21-4300 |
| Skin |
Keratosis |
O20-4325 |
O21-4325 |
| |
Melanoma |
O20-4350 |
O21-4350 |
| |
Psoriases |
O20-4375 |
O21-4375 |
| |
Squamous intraepithelial lesion |
O20-4400 |
O21-4400 |
| Spleen |
Endometrioid adenocarcinoma |
O20-4425 |
O21-4425 |
| |
Malignant lymphoma |
O20-4450 |
O21-4450 |
| |
Malignant melanoma |
O20-4475 |
O21-4475 |
| |
Non-Hodgkin lymphoma |
O20-4500 |
O21-4500 |
| |
Splenomegaly |
O20-4525 |
O21-4525 |
| Stomach |
Adenocarcinoma |
O20-4550 |
O21-4550 |
| |
Carcinoid tumor |
O20-4575 |
O21-4575 |
| |
|
|
|
| Testes |
Seminoma |
O20-4600 |
O21-4600 |
| |
Clear cell Cystadenocarcinoma |
O20-4625 |
O21-4625 |
| |
Squamous cell carcinoma |
O20-4650 |
O21-4650 |
| Thymus |
Thymoma |
O20-4675 |
O21-4675 |
| Thyroid |
Papillary carcinoma |
O20-4700 |
O21-4700 |
| |
Adenomatoid nodule |
O20-4725 |
O21-4725 |
| |
Follicular adenoma |
O20-4750 |
O21-4750 |
| |
Paraganglioma |
O20-4775 |
O21-4775 |
| |
Nodular hyperplasia with associated hematoma |
O20-4800 |
O21-4800 |
| |
Myxoid liposarcoma |
O20-4825 |
O21-4825 |
| |
Carcinoma |
O20-4850 |
O21-4850 |
| |
Thymoma |
O20-4875 |
O21-4875 |
| |
Lymphocytic thyroiditis |
O20-4900 |
O21-4900 |
| |
Follicular adenoma |
O20-4925 |
O21-4925 |
| Tongue |
Squamous cell carcinoma |
O20-4950 |
O21-4950 |
| |
|
|
|
| Uterus |
Papillary serous carcinoma |
O20-4975 |
O21-4975 |
| Uvula |
Squamous cell carcinoma |
O20-5000 |
O21-5000 |
| |
|
|
|
| Vagina |
Carcinoma |
O20-5025 |
O21-5025 |
| Vagus nerves |
Schwannoma |
O20-5050 |
O21-5050 |
| Vulva |
Squamous cell carcinoma |
O20-5075 |
O21-5075 |
| |
Condyloma acuminatum |
O20-5100 |
O21-5100 |
